Skip to content Skip to navigation

Medication Treatments

Oxytocin a potential treatment for addiction and comorbid mood disorders

April 21, 2017  |  Tom Valentino, Senior Editor
article
A research review published in the British Journal of Pharmacology suggests the neuropeptide oxytocin, administered as an intranasal spray, could be effective in the treatment of opioid addiction and comorbid mood disorders.

Rx Summit: Unlikely political duo teams up for science-based care

April 19, 2017  |  Gary A. Enos, Editor
article
Newt Gingrich and Patrick Kennedy have at least one thing in common: an absolute reverence for brain research that can inform solutions to the opioid crisis.

Rx Summit: Local solutions to crisis require collective effort

April 17, 2017  |  Gary A. Enos, Editor
article
Small counties in California are reducing improper opioid prescribing and expanding addiction treatment through the efforts of groups that include an insurer and a major foundation.

Could a device attached to the ear become a game-changer in detox?

April 12, 2017  |  Gary A. Enos, Editor
article
An electrical stimulation device that is approved for pain is gaining use as a method of easing withdrawal from opioids and facilitating access to longer-term treatment.

Harvard course on opioids has relevance for professionals, public

April 7, 2017  |  Gary A. Enos, Editor
article
As part of its public health mission, Harvard Medical School's Harvard Health Publications has introduced a self-guided opioid course that is proving popular among treatment professionals and the public.

Ohio enacts limits on prescribing for acute pain

April 4, 2017  |  Gary A. Enos, Editor
news
New regulations on opioid prescribing in Ohio arrive at a time when some lawmakers are advocating even stricter limits.

Brightside Clinic hires medical director

March 20, 2017  |  Gary A. Enos, Editor
news
David Kushner, DO, FACP, has been named medical director at Brightside Clinic, the buprenorphine treatment organization with offices in two Illinois communities.

Report: Risk of long-term opioid use increases in initial week of treatment

March 17, 2017  |  Gary A. Enos, Editor
article
Data released this week by the Centers for Disease Control and Prevention (CDC) make a case for significant limits on initial prescriptions of opioids.

Study highlights threat of dual use of buprenorphine and other opioids

March 7, 2017  |  Rachael Zimlich, RN, Contributing Writer
article
Research using a pharmacy database leads to striking findings about the prevalence of other opioid use during and after buprenorphine treatment.

Readers open to idea of marijuana-inclusive treatment

February 28, 2017  |  Tom Valentino, Senior Editor
blog
Our story last week on the use of marijuana in addiction treatment has generated a lot of reader feedback, with many commenters willing to consider the practice.

Treatment that includes marijuana use ignites debate

February 21, 2017  |  Tom Valentino, Senior Editor
article
High Sobriety in West Los Angeles is the latest example of treatment centers using marijuana as part of treatment for addiction to alcohol and other drugs, a highly polarizing practice.

Researchers quantify benefit of medication intervention in emergency care

February 14, 2017  |  Gary A. Enos, Editor
news
New research suggests that opioid-addicted individuals who receive buprenorphine during an emergency medical visit show better treatment engagement for two months following the intervention.

Pages

Subscribe to Medication Treatments